Open Access<p>Registrations of Patients with Renal Cell Carcinoma in the Nationwide Danish Renal Cancer Database versus the Danish Cancer Registry: Data Quality, Completeness and Survival (DaRenCa Study-3)</p>
Author(s) -
Bolette Danckert,
Trine Allerslev Horsbøl,
O. Ortved Andersen,
Susanne Oksbjerg Dalton,
Jane Christensen,
Margit Caroline Rasted,
Astrid Petersen,
Mette Nørgaard,
Nessn Azawi,
Lars Lund,
Frede Donskov
Publication year - 2020
Publication title -
clinical epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.868
H-Index - 58
ISSN - 1179-1349
DOI - 10.2147/clep.s258755
Subject(s) - medicine , danish , hazard ratio , cancer registry , renal cell carcinoma , cancer , proportional hazards model , relative survival , kidney cancer , database , confidence interval , philosophy , linguistics , computer science
The Danish multidisciplinary renal cancer group (DaRenCa) established the nationwide database DaRenCaData in 2010. The Danish Cancer Registry (DCR) has been considered the golden standard. In contrast to DCR, DaRenCaData required the diagnosis to be histologically or cytologically verified. DaRenCaData and DCR have not previously been compared.